National Center for Tumor Diseases (NCT), Division of Preventive Oncology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 460, Heidelberg 69120, Germany.
Cancer Prev Res (Phila). 2013 Mar;6(3):217-31. doi: 10.1158/1940-6207.CAPR-12-0212. Epub 2013 Jan 22.
Adipose tissue plays a role in obesity-related cancers via increased production of inflammatory factors, steroid hormones, and altered adipokines. The impact of weight loss on adipose tissue gene expression may provide insights into pathways linking obesity with cancer risk. We conducted an ancillary study within a randomized trial of diet, exercise, or combined diet + exercise versus control among overweight/obese postmenopausal women. In 45 women, subcutaneous adipose tissue biopsies were conducted at baseline and after 6 months, and changes in adipose tissue gene expression were determined by microarray with an emphasis on prespecified candidate pathways as well as by unsupervised clustering of more than 37,000 transcripts (Illumina). Analyses were conducted first by randomization group and then by degree of weight change at 6-months in all women combined. At 6 months, diet, exercise, and diet + exercise participants lost a mean of 8.8, 2.5, and 7.9 kg (all P < 0.05 vs. no change in controls). There was no significant change in candidate gene expression by intervention group. In analysis by weight change category, greater weight loss was associated a decrease in 17β-hydroxysteroid dehydrogenase-1 (HSD17B1, Ptrend < 0.01) and leptin (LEP, Ptrend < 0.01) expression, and marginally significant increased expression of estrogen receptor-1 (ESR1, Ptrend = 0.08) and insulin-like growth factor-binding protein-3 (IGFBP3, Ptrend = 0.08). Unsupervised clustering revealed 83 transcripts with statistically significant changes. Multiple gene expression changes correlated with changes in associated serum biomarkers. Weight loss was associated with changes in adipose tissue gene expression after 6 months, particularly in two pathways postulated to link obesity and cancer, that is, steroid hormone metabolism and IGF signaling. Cancer Prev Res; 6(3); 217-31. ©2013 AACR.
脂肪组织通过增加炎症因子、类固醇激素和改变脂肪因子的产生,在肥胖相关癌症中发挥作用。体重减轻对脂肪组织基因表达的影响可能为肥胖与癌症风险之间的联系提供线索。我们在一项针对超重/肥胖绝经后妇女的饮食、运动或联合饮食+运动与对照组的随机试验中进行了一项辅助研究。在 45 名女性中,在基线和 6 个月时进行了皮下脂肪组织活检,并通过微阵列确定脂肪组织基因表达的变化,重点是预先指定的候选途径以及超过 37000 个转录本的无监督聚类(Illumina)。首先按随机分组进行分析,然后按所有女性 6 个月时的体重变化程度进行分析。在 6 个月时,饮食、运动和饮食+运动组分别平均减轻 8.8、2.5 和 7.9 公斤(均 P < 0.05 与对照组无变化相比)。干预组候选基因表达无显著变化。按体重减轻类别分析,体重减轻较多与 17β-羟甾脱氢酶-1(HSD17B1,Ptrend < 0.01)和瘦素(LEP,Ptrend < 0.01)表达减少有关,雌激素受体-1(ESR1,Ptrend = 0.08)和胰岛素样生长因子结合蛋白-3(IGFBP3,Ptrend = 0.08)表达略有增加。无监督聚类显示 83 个转录本有统计学意义的变化。多个基因表达变化与相关血清生物标志物的变化相关。6 个月后,体重减轻与脂肪组织基因表达的变化有关,特别是在两个被认为与肥胖和癌症有关的途径中,即类固醇激素代谢和 IGF 信号转导。癌症预防研究;6(3);217-31. 2013 AACR。